| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.5M | -19.4% | +12.0% |
| Cost of Revenue | $3.2M | -49.5% | +36.9% |
| Gross Profit | $1.4M | +316.8% | -21.2% |
| R&D Expense | $138K | -25.1% | -34.7% |
| SG&A Expense | $2.5M | -28.0% | -72.7% |
| Operating Income | -$1.1M | +72.6% | +84.8% |
| Interest Expense | $91K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $793K | +27.4% | +91.1% |
| Accounts Receivable | $1.3M | +30.4% | -21.3% |
| Inventory | $2.6M | +6.3% | +12.8% |
| Current Assets | $9.7M | +0.1% | -32.4% |
| Total Assets | $25.1M | -3.4% | -22.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | — |
| Capital Expenditures | $263K | — | — |
| Investing Cash Flow | -$349K | — | — |
| Financing Cash Flow | $9.7M | — | — |
| Free Cash Flow | -$9.3M | — | — |
| — |
| -88.2% |
| Pre-tax Income | -$963K | +78.5% | +82.4% |
| Net Income | -$963K | +78.5% | +82.4% |
| EPS (Basic) | -$0.59 | +81.6% | +35.2% |
| EPS (Diluted) | -$0.59 | +81.6% | +35.2% |
| $9.8M |
| +2.6% |
| -64.4% |
| Long-term Debt | $1.0M | +35.1% | -72.0% |
| Total Liabilities | $17.6M | -1.4% | -49.4% |
| Stockholders' Equity | $7.5M | -7.8% | +407.0% |